





Respiratory Parameters for the Classification of Dysfunctional
Insulin Secretion by Pancreatic Islets
Uma D. Kabra 1,2 , Charles Affourtit 3 and Martin Jastroch 4,5,*


Citation: Kabra, U.D.; Affourtit, C.;
Jastroch, M. Respiratory Parameters for
the Classification of Dysfunctional
Insulin Secretion by Pancreatic Islets.
Metabolites 2021, 11, 405. https://
doi.org/10.3390/metabo11060405
Academic Editors: Melkam Kebede
and Belinda Yau
Received: 3 June 2021
Accepted: 18 June 2021
Published: 21 June 2021
Publisher’s Note: MDPI stays neutral
with regard to jurisdictional claims in
published maps and institutional affil-
iations.
Copyright: © 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
1 Division of Metabolic Diseases, Technische Universität München, 80333 Munich, Germany;
uma.kabra16205@paruluniversity.ac.in
2 Department of Pharmaceutical Chemistry, Parul Institute of Pharmacy, Parul University,
Vadodara 391760, India
3 Faculty of Health, School of Biomedical Sciences, University of Plymouth, Plymouth Science Park,
Plymouth PL6 8BU, UK; charles.affourtit@plymouth.ac.uk
4 Department of Molecular Biosciences, The Wenner-Gren Institute, The Arrhenius Laboratories F3, Stockholm
University, SE-106 91 Stockholm, Sweden
5 Helmholtz Diabetes Center, Institute for Diabetes and Obesity, Helmholtz Zentrum München, German
Research Center for Environmental Health (GmbH), 85764 Neuherberg, Germany
* Correspondence: martin.jastroch@su.se; Tel.: +46-720836997
Abstract: The development of obesity and type 2 diabetes (T2D) has been associated with impaired
mitochondrial function. In pancreatic beta (β) cells, mitochondrial energy metabolism plays a central
role in triggering and controlling glucose-stimulated insulin secretion (GSIS). Here, we have explored
whether mitochondrial bioenergetic parameters assessed with Seahorse extracellular flux technology
can quantitatively predict insulin secretion. We metabolically stressed male C57BL/6 mice by high-fat
feeding (HFD) and measured the glucose sensitivity of islet respiration and insulin secretion. The
diet-induced obese (DIO) mice developed hyperinsulinemia, but no pathological secretory differences
were apparent between isolated DIO and chow islets. Real-time extracellular flux analysis, however,
revealed a lower respiratory sensitivity to glucose in DIO islets. Correlation of insulin secretion with
respiratory parameters uncovers compromised insulin secretion in DIO islets by oxidative power.
Normalization to increased insulin contents during DIO improves the quantitative relation between
GSIS and respiration, allowing to classify dysfunctional properties of pancreatic insulin secretion,
and thereby serving as valuable biomarker for pancreatic islet glucose responsiveness and health.
Keywords: mitochondria; bioenergetics; glucose-stimulated insulin secretion; pancreatic islets; respi-
ration
1. Introduction
Pancreatic β cells are specialized endocrine cells that integrate signals from glucose
and other fuels to control the secretion of insulin [1]. Glucose induces insulin secretion via
both triggering and amplifying pathways [2]. The triggering pathway involves oxidative
glucose catabolism, a rise in the cytosolic adenosine triphosphate/adenosine diphosphate
(ATP/ADP) ratio, closure of ATP-sensitive potassium (KATP) channels, depolarization of
the plasma membrane, influx of calcium ions, and eventual exocytosis of insulin-containing
granules [3–5]. The amplifying pathways boost this glucose-stimulated insulin secretion
(GSIS) in a KATP-channel-independent (but Ca2+-dependent) way [4,6]. Many steps of
the β cell insulin secretory pathways can affect the efficiency of insulin secretion. Mito-
chondria are intimately involved in glucose catabolism because oxidative phosphorylation
has control over the ATP/ADP ratio and, thus, GSIS [7]. Oxidative phosphorylation is
ideally assessed by combining respiratory flux and mitochondrial membrane potential
measurements [8,9]. While mitochondrial membrane potential measurements of β cell
mitochondria are challenging in intact β cells because of glucose-evoked plasma membrane
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potential fluctuations [10], cellular respiratory flux measurements are relatively straight-
forward [11]. Several parameters are readily calculated from whole-cell oxygen uptake to
give insight in the efficiency by which energy liberated from oxidative glucose breakdown
is conserved as ATP. These parameters include glucose sensitivity (GS), i.e., the magnitude
of respirational increase upon glucose stimulus, and coupling efficiency (CE) of oxidative
phosphorylation, i.e., the part of mitochondrial respiration coupled to ATP synthesis [8].
Notably, these bioenergetic parameters are internally normalized and, thus, dimensionless,
which renders them more sensitive indicators of oxidative phosphorylation than absolute
oxygen uptake rates [8]. For example, CE has been instrumental for demonstrating a glu-
cose sensitivity of oxidative phosphorylation in INS-1E insulinoma cells that is regulated
by mitochondrial uncoupling protein-2 [12]. This bioenergetic regulation is reflected by
insulin secretion activity, which suggests the possibility that CE has broader predictive
power that may be exploited to forecast β cell dysfunction.
In this study, we correlated mitochondrial respiration and insulin secretion in pan-
creatic islets from chow-fed and diet-induced obese (DIO) mice, with the aim to identify
parameters that allow classification of insulin secretion deficiencies. DIO mice represent a
model of a well-established risk scenario in which obesity leads to insulin resistance, β cell
dysfunction, and eventually type 2 diabetes mellitus [13]. Our findings suggest that loss of
mitochondrial respiratory sensitivity to glucose is an early warning sign for compromised
insulin secretion.
2. Results and Discussion
2.1. Inducing Metabolic Stress in Mice
We tested our hypothesis on the relation between respiration and insulin secretion
in DIO mice, a typical model for the development of insulin resistance and hyperinsu-
linemia. Male C57BL/6 mice were kept on high-fat diet (HFD) for 16 weeks to induce
obesity (~45.8 g HFD vs. ~28.8 g chow; Figure 1A). Plasma insulin levels were dramat-
ically increased (Figure 1B). However, plasma glucose levels were unchanged (Figure
1C), suggesting that hyperinsulinemia was sufficient to compensate insulin resistance in
HFD mice.
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Figure 1. Characterization of chow (black bars) and HFD (white bars) fed C57BL/6 mice. (A) Body weight; (B) plasma 
insulin level; and (C) plasma glucose levels. The mice were 8 weeks old at the start of the feeding experiment. Data are 
represented as ± SEM (n = 8 mice per group). Statistical significance of mean differences was tested by unpaired two-tailed 
student t-test. p < 0.001 (***). 
2.2. Respiratory Activity but Not Insulin Secretion Is Impaired in Islets of DIO Mice 
Interestingly, the assessment of insulin secretion between chow and DIO islets re-
vealed no differences (Figure 2A). In contrast, averaged real-time oxygen consumption 
traces in Figure 2B demonstrate clearly that respiration in DIO islets differs drastically 
Figure 1. Characterization of chow (black bars) and HFD (white bars) fed C57BL/6 mice. (A) Body weight; (B) plasma
insulin level; and (C) plasma glucose levels. The mice were 8 weeks old at the start of the feeding experiment. Data are
represented as ± SEM (n = 8 mice per group). Statistical significance of mean differences was tested by unpaired two-tailed
student t-test. p < 0.001 (***).
2. Respiratory Activ ty but Not Insulin Secretion Is Impaired in Islets of DIO Mice
Inter stingly, the asse sment of insulin secretion between chow and DIO islets re-
vealed no differ nces (Figure 2A). In contrast, averaged real-time oxygen consumption
traces in Figure 2B demonstrate clearly that respiration in DIO islets differs drastically
from that exhibited by their control counterparts. After normalizing oxygen uptake to
DNA content and correcting respiratory activity for non-mitochondrial (i.e., rotenone-and-
antimycin-A-resistant) oxygen consumption, it transpired that there was no difference in
basal respiration between the two systems (Figure 2C). However, the strong respiratory
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stimulation provoked by glucose in control islets was more than halved in DIO islets
(Figure 2D,E), which was the combined result of attenuated respiration linked to mito-
chondrial proton leak (Figure 2F) and ATP synthesis (Figure 2G). In other words, both
oligomycin-sensitive and -insensitive oxygen uptake was decreased by DIO, which ex-
plains why the CE of oxidative phosphorylation, which reflects the oligomycin sensitivity
of overall glucose-stimulated respiration (GSR), was not affected to a statistically significant
degree (Figure 2H). The reduction of both proton leak and ATP-linked respiration can be
indicative of compromised substrate oxidation capacity [8]. Next, we plotted absolute
secreted insulin values vs respiratory parameters related to insulin triggering (ATP-linked
respiration and GSR), and assessed their relation by correlation analysis. Within chow islets,
insulin values correlate significantly with ATP-linked respiration and GSR (Figure 2I,J).
This relationship appeared to be shifted upwards in DIO islets (dotted regression line).
In our experimental conditions in vitro, however, no secretagogues or other amplifying
mechanisms are present, to the best of our knowledge, which could selectively act on DIO
islets. However, we cannot formally exclude amplifying factors deriving from glucose
catabolism [14], and we thus refer to altered secretory pathways of insulin secretion rather
than to altered triggering of insulin secretion.
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Figure 2. Glucose-stimulated insulin secretion and mitochondrial bioenergetics of pancreatic islets from chow and HFD-
fed mice. (A) Insulin secretion. Batches of eight size-matched islets were exposed to either 2 or 16.5 mM glucose for 1 h 
before supernatants and lysates were collected. (B) Representative time-resolved oxygen consumption traces. Batches of 
30 size-matched islets were exposed to 2 mM glucose to assess basal respiration (4 cycles), glucose-stimulated respiration 
(10 cycles), proton leak respiration by inhibition of ATP synthase using oligomycin (10 cycles), and non-mitochondrial 
respiration by final injection of rotenone/antimycin A. (C) Mitochondrial basal respiration at low glucose (2 mM). (D) 
Glucose-stimulated respiration expressed as percentage of basal (E) Mitochondrial stimulated respiration at high glucose 
(16.5 mM). (F) Proton leak respiration at high glucose. (G) ATP-linked respiration at high glucose. (H) Coupling effi-
ciency at high glucose. (I) Correlation of insulin secretion (absolute values) and ATP-linked respiration. (J) Correlation of 
insulin secretion (absolute values) and glucose-stimulated respiration. Data are represented as means ± SEM (n = 6 mice 
Figure 2. Glucose-stimulated insulin secretion and mitochondrial bioenergetics of pancreatic islets
from chow and HFD-fed mice. (A) Insulin secretion. Batches of eight size-matched islets were
exposed to either 2 o 16.5 mM glucose for 1 h befor supernatants and lysates we e collected. (B)
Representative time-resolved oxygen consumption traces. Batches of 30 size-matched islets were
exposed to 2 mM glucose to assess basal respiration (4 cycles), glucose-stimulated respiration (10
cycles), proton leak respiration by inhibition of ATP synthase using oligomycin (10 cycles), and
non-mitochondrial respirat on by final injection of rot none/antimycin A. (C) Mitochondrial basal
respiration at low glucose (2 mM). (D) Glucose-stimulated respiration expressed as percentage of
basal (E) Mitochondrial stimulated respiration at high glucose (16.5 mM). (F) Proton leak respiration
at high glucose. (G) ATP-linked respiration at high glucose. (H) Coupling efficiency at high glucose.
(I) Correlation of insulin secretion (absolute values) and ATP-linked respiration. (J) Correlation of
insulin secretion (absolute values) and glucose-stimulated respiration. Data are represented as means
± SEM (n = 6 mice per group, each mouse was considered as independent experiment and islets were
plated in triplicate). Statistical significance of mean differences was tested by unpaired two-tailed
student t-test. p < 0.05 (*), p < 0.001 (***).
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2.3. Compensating Increase of Insulin Content in DIO Islets Masks Defects of the
Triggering Pathway
Exploring compensatory responses to loss of insulin sensitivity in HFD mice (Figure 1),
we found a 15% higher insulin content in DIO islets (Figure 3A), consistent with increases
in β cell proliferation during DIO [15]. Normalizing insulin secretion to insulin content,
GSIS of the DIO islets was lower than that from control islets (Figure 3B). Importantly,
plotting GSIS values normalized to insulin content shifted DIO insulin values onto the
regression of chow islets, with a better regression to glucose-stimulated than to ATP-linked
respiration (Figure 3C,D). Insulin secretion correlates less well with coupling efficiency
(CE, Figure 3E), but it should be noted that the internal standardization benefits data
comparisons between different experimental settings and laboratories. The normalization-
dependency of the GSIS phenotype suggests that DIO islets respond to an obesity-induced
drop in glucose sensitivity by increasing insulin content, a response that appears to fix the
secretory impairment.
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Figure 3. Glucose-stimulated insulin secretion in chow and HFD mice. Batches of eight size-matched
islets were exposed to either 2 or 16.5 mM glucose for 1 h at which point supernatants and lysates
were collected for (A) insulin content, and (B) secreted insulin measurements. Correlation between
insulin secretion (% content) and (C) glucose-stimulated respiration, (D) ATP-linked respiration,
and (E) coupling efficiency (F) correlation model classifying defects of insulin secretion. Data are
represented as means ± SEM (n = 6 mice per group, each mouse was considered as independent
experiment and islets were plated in triplicate). Statistical significance of mean differences was tested
by unpaired two-tailed student t-test. p < 0.05 (*), p < 0.001 (***).
2.4. Classifying Defects in Insulin Secretion
From Figure 3C–E, it transpires that secreted insulin values require normalization to
insulin content to establish a robust linear relationship between insulin and bioenergetics
parameters. The relationship between oxidative phosphorylation and GSIS leads to a
simple linear correlation model to classify defects of insulin secretion (Figure 3F). In
relation to control values, descending along the regression line suggests reduced oxidative
power by either compromised substrate delivery or respiratory dysfunction. In the case
of DIO islets, the secretory pathway is compromised by reduced oxidative power, which
could be mediated by impaired glucose uptake, glycolysis, or pyruvate oxidation—the
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latter being recently suggested in response to impaired mitochondrial dynamics [16] or
inflammation [17]. In contrast, ascending values suggest improved substrate delivery or
oxidative phosphorylation. Upwards deviation from regression is explained by amplifying
pathways, while downwards deviation points towards secretory dysfunction downstream
or no mitochondrial impact.
3. Materials and Methods
Animals—male C57BL/6 mice with an age of 8 to 10 weeks were purchased from
Janvier Labs (Le Genest-Saint-Isle, France). The animals were maintained on a 12/12
h light/dark cycle in a temperature-controlled environment and allowed free access to
standard chow diet (5.6% fat, LM-485, Harlan Teklad) or a high-fat diet (HFD) (58% kcal
fat; Research Diets Inc., New Brunswick, NJ, USA) for 16 weeks. All in vivo procedures
were conducted under the guidelines of the Institutional Animal Care Committee of the
Helmholtz Center Munich, which approved all animal maintenance and experimental
procedures. The animal experiments complied with all ethical regulations for animal
testing and research, including animal maintenance and experimental procedures that
the animal welfare authorities of the local animal ethics committee of the state of Bavaria
(Regierung Oberbayern) approved in accordance with European guidelines.
Islet isolation and culture—mouse islets were isolated by digestion with collagenase
as described elsewhere [12]. Around 150–200 islets were obtained per mouse. Islets were
incubated overnight in RPMI 1640 culture medium supplemented with 10% (v/v) fetal calf
serum (Life technologies) at 37 ◦C and 5% CO2 before experimentation.
Insulin secretion—groups of eight size-matched islets were handpicked into individual
wells of V-bottomed 96-well plates and incubated for 60 min at 37 ◦C in HEPES-balanced
Krebs-Ringer (KRH) bicarbonate buffer containing 114 mM NaCl, 4.7 mM KCl, 2.5 mM
CaCl2, 1.16 mM MgSO4, 1.2 mM KH2PO4, 25.5 mM NaHCO3, 20 mM HEPES (pH 7.2–7.4),
supplemented with 0.2% (w/v) bovine serum albumin (BSA), and 2 mM glucose. The islets
were then incubated for a further 60 min in KRH-bicarbonate buffer containing 2 or 16.5 mM
glucose. Subsequently, supernatants were collected to quantify secreted insulin. Following
the secretion assay, islets were lysed with ice-cold RIPA buffer to allow total insulin content
to be determined. Insulin was detected with the Ultra-Sensitive Mouse Insulin Elisa Kit
(ALPCO, Salem, NH, USA). Data were normalized to DNA content measured with the
Quant-it Pico Green DNA assay kit (Invitrogen, Darmstadt, Germany).
Mitochondrial respiration—oxygen consumption rates (OCR) were measured in islet-
capture plates of the XF24 extracellular flux analyzer (Agilent, Seahorse Bioscience, Santa
Clara, CA, USA). Briefly, groups of 30 size-matched islets were handpicked into individ-
ual wells of islet capture plates and incubated for 60 min at 37 ◦C without CO2 in KRH-
bicarbonate free buffer containing 2 mM glucose. Additional glucose (16.5 mM), oligomycin
(10 µg/mL), and a mixture of rotenone and antimycin A (both 2 µM) were injected se-
quentially. Mitochondrial respiration was calculated by subtracting non-mitochondrial
respiration from all other oxygen uptake rates. The individual bioenergetics parameters of
OXPHOS parameters were calculated as follows: basal mitochondrial respiration = (last
rate measured before glucose and/or other secretagogues injection) − (non-mitochondrial
respiration rate). Glucose-stimulated mitochondrial respiration = (last rate measured
before oligomycin injection) − (non-mitochondrial respiration rate). Proton-leak-linked
respiration = (minimum rate measured after oligomycin injection) − (non-mitochondrial
respiration rate). ATP-synthesis-linked respiration = (glucose-stimulated mitochondrial
respiration) − (proton leak-linked respiration). Coupling efficiency = the fraction of res-
piration used to drive ATP synthesis for each run, calculated as CE = 1 − (proton-leak-
linked respiration/mitochondrial glucose-stimulated respiration). Data were normalized
to DNA content.
Metabolic tests—mice were fasted for six hours prior to blood collection. Blood
samples taken from the tail vein were used to measure glycaemia with a glucometer
(Abbott, Wiesbaden, Germany) and insulin by ELISA.
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Statistical analysis—statistical analysis was performed with GraphPad Prism ver-
sion 6.0. The data passed normality tests (Shapiro–Wilk and Kolmogorov–Smirnov test)
and the groups were compared using unpaired Student’s t test. All the data are shown
as mean ± standard error of mean (S.E.M). p values < 0.05 were considered statistically
significant.
4. Conclusions
In this study, we demonstrate that mitochondrial respiratory parameters have predic-
tive value for insulin secretion from pancreatic β cells. In a typical model for metabolic
disease, DIO mice, we found that defective insulin secretion is compensated by increased
insulin content. Although absolute values of insulin secretion are not affected, mitochon-
drial respiration is severely compromised in DIO islets. Correlation of respiration and
GSIS is firmly established by normalizing GSIS to insulin content, showing that mitochon-
drial respiratory parameters quantitatively predict changes in GSIS. Absolute values of
ATP-linked respiration and GSR predict insulin release the best, while CE is less predictive.
CE, however, is a powerful bioenergetic parameter that has been successfully applied to
uncover molecular mechanisms in mitochondria, e.g., the role of UCP2 in β cells [8]. CE
is based on the thermodynamic laws of energy conversion that mitochondrial oxidation
energy is either converted to ATP or lost as heat due to the mitochondrial proton leak. CE
is defined as the fraction of energy that is converted to ATP (thus ranging from 0 to 1). As
internally standardized parameter, CE is not prone to variation in absolute values between
independent experiments. Although CE correlates with GSIS, the relation is steeper and
more variable concerning linear regression, as compared to ATP-linked respiration and GSR
in our experimental setup. Thus, CE may only be used to compare independent studies.
However, the relation of CE and GSIS suggests a “threshold” CE value that is required to
trigger insulin secretion. Considering previous studies from our laboratory [16,18], we find
a tight CE of about 0.4–0.6 as requirement for insulin triggering in islets and in β cell mod-
els. Based on the results we designed a model correlating GSR or ATP linked respiration
vs. insulin secretion that allows classifying dysfunctional properties of pancreatic insulin
secretion under pathological conditions. All these analyses suggest that mitochondrial
bioenergetic parameters reflect insulin secretion in a quantifiable manner, and may thus
serve as biomarkers for glucose responsiveness and pancreatic islet health.
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